NCT00755313View on ClinicalTrials.gov

Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer

CompletedOBSERVATIONAL
Enrollment

81

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

September 30, 2012

Study Completion Date

June 6, 2014

Conditions
Breast CancerChemotherapeutic Agent ToxicityCognitive/Functional EffectsFatigueLong-term Effects Secondary to Cancer Therapy in AdultsNeurotoxicityPsychosocial Effects of Cancer and Its Treatment
Interventions
BIOLOGICAL

trastuzumab

DRUG

aromatase inhibition therapy

DRUG

carboplatin

DRUG

cyclophosphamide

DRUG

docetaxel

DRUG

doxorubicin hydrochloride

OTHER

metabolic assessment

OTHER

questionnaire administration

OTHER

study of socioeconomic and demographic variables

PROCEDURE

cognitive assessment

PROCEDURE

positron emission tomography

RADIATION

fludeoxyglucose F 18

Trial Locations (1)

94115

UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of California, San Francisco

OTHER

NCT00755313 - Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer | Biotech Hunter | Biotech Hunter